Crimson Publishers- Novel Approaches in Cancer Study

The Role of MicroRNAs in the Progression, Prognostication, and Treatment of Breast Cancer by Yi Lu in Journal of Cancer Research   Crimson Publishers _  Novel Approaches in Cancer Study   MicroRNAs (miRNAs) are conserved, small, non-coding RNA molecules, which recently have attracted enormous attention in numerous physiological and pathological conditions. Several studies have shed light on their biogenesis, regulatory mechanisms, and role as effective therapies in diseased conditions. Of interest, miRNA deregulation in numerous cancer types has been researched as potential diagnostic and prognostic tool. Breast cancer (BCa) is the most predominant tumor in women and the main cause of death. Despite advances in diagnosis and new treatments, the death toll from this disease is still higher than many other types of cancer in men and women. A major global health issue plaguing the health and clinical research industry is resistance to BCa treatments. A lot of attention is i...

 Orofacial Cancer, Personal Views and Experience by Raja Kummoona in Journal of Cancer Research   Crimson Publishers _  Novel Approaches in Cancer Study Cancer is a dreadful disease always end with death, but some cases may respond to treatment and some not, It’s a frightening disease to the community. The survival rate in best cases for 5 years. Head Neck cancer represent nearly 8% of the total body malignancy including the Orofacial region, oropharynx, parotid glands and other salivary glands, Orbit, jaws and skin. Most of these organs affected by squamous cell carcinoma, other varieties of cancer of fibrosarcoma, osteogenic sarcoma, Kummoona jaw lymphoma, non-Hodgkin’s and Hodgkin’s lymphoma other varieties of cancer are basal cell carcinoma effecting skin of white people due to sun light effect, its locally invasive and don’t metastasis unless transformed to squamous cell carcinoma. Oral cancer represents about 4% of total malignancies but might raise to 40% in India ...

Immunotherapy for Hepatocellular Carcinoma by Li Xiaowu in Journal of Cancer Research   Crimson Publishers _  Novel Approaches in Cancer Study Hepatocellular carcinoma (HCC) has always been a difficult medical problem for the increasing mortality rate. According to the World Health Organization (WHO), hepatocellular carcinoma (HCC) is the fourth-leading cause of cancer related deaths worldwide [1] and is considered as a highly refractory cancer. Surgery is the most effective treatment to HCC, but HCC is resistant to conventional chemotherapy. In recent years, immunotherapy has been attracting growing attention as a promising therapeutic method to HCC. Immunotherapies to HCC including chimeric antigen receptor T cells (CAR-T), immune checkpoint inhibitor and oncolytic virus have become research hotspots. https://crimsonpublishers.com/nacs/fulltext/NACS.000580.php For more Open Access Journals in Crimson Publishers please click on: https://crimson-publishers.blogspot.com/2019/1...